SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are facing significant intraday volatility following a strong fiscal first-quarter earnings report, with the community divided between long-term bullish sentiment regarding the company's cloud infrastructure backlog and frustration over perceived market maker manipulation. While many traders see the pullbacks as a "shakeout" or options-related noise, others cite concerns over debt levels and negative free cash flow as justification for the price weakness.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo shares are facing downward pressure following the announcement of a new $1 billion at-the-market equity offering program, which has triggered widespread concerns among traders regarding potential dilution. While the community remains deeply divided between long-term investors focused on the company's nuclear energy pipeline and short-term traders reacting to persistent insider selling and lack of immediate revenue, many are closely monitoring critical support levels.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is experiencing significant downward pressure following a UBS downgrade to 'Sell' with a slashed price target, as analysts and traders cite concerns over long build timelines, cash burn, and the lack of firm commercial commitments. While some market participants remain optimistic about the company's long-term potential in the nuclear energy sector, others are increasingly critical of the firm's minimal revenue and execution risks.

Alliance Entertainment Holding Corp. engages in the distribution of music, movies, and consumer electronics. It distributes its physical media, entertainment products, hardware, and accessories through an established multi-channel strategy. The company was founded in 1990 and is headquartered in Plantation, FL.

Alliance Entertainment Holding Corporation - Ordinary Shares - Class A

AENT is trending as traders analyze the company's recent earnings beat, with discussion focused on the potential for a rebound driven by its low float and exclusive physical media distribution partnerships. While some community members are optimistic about institutional support and growth opportunities in collectibles, others express skepticism regarding insider activity and the sustainability of recent price volatility.

Dell Technologies, Inc. is a technology company, providing customers with a broad and innovative solution portfolio to help customers modernize their information technology (IT) infrastructure, address workforce transformation, and offer critical solutions that keep people and organizations connected. It operates through the following segments: Infrastructure Solutions Group (ISG) and Client Solutions Group (CSG). The ISG segment includes servers, networking, and storage, as well as services and third-party software and peripherals that are closely tied to the sale of ISG hardware. The CSG segment includes designs for commercial and consumer customers of desktops, thin client products, and notebooks. The company was founded by Michael Saul Dell in 1984 and is headquartered in Round Rock, TX.

Dell Technologies Inc - Ordinary Shares - Class C

Dell Technologies Inc

Dell shares are trending following the company's strong fiscal quarterly results, which featured robust AI server demand and a massive order backlog, leading to upward price target revisions from analysts. While bullish traders emphasize the company's leadership in the AI infrastructure buildout and new S&P 100 inclusion, bearish sentiment is fueled by concerns over heavy insider selling, large debt offerings, and skepticism regarding the sustainability of the AI-driven valuation.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending as traders speculate on the timing and results of upcoming maintenance study data for its obesity candidate, VK2735. While some investors remain optimistic about potential buyout interest and the drug's efficacy, others express frustration over the company's communication style and lack of immediate news.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending due to anticipation of upcoming earnings on September 15th, with traders expressing strong bullish sentiment based on the company's role in the power infrastructure and data center buildout. While some participants express frustration over recent price volatility and insider selling, others highlight the company's significant backlog and electrification demand as indicators for long-term growth.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is trending as traders debate the company's valuation and potential turnaround, with discussion focused on heavy insider buying and speculation regarding the possible sale of the STAR debit network. While some investors view the current price as a long-term value opportunity, others express significant frustration over management execution and weak performance, maintaining a bearish outlook until there is clear evidence of a recovery.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is facing significant selling pressure and negative sentiment following the release of Phase 3 IZAR-1 trial data, which traders viewed as failing to demonstrate a clear best-in-class efficacy profile, alongside the filing of a mixed shelf offering. Community discussion is heavily divided between those who remain optimistic about the company's long-term potential in hidradenitis suppurativa and those expressing frustration with management's communication, perceived lack of transparency, and dilution risks.

Pagaya Technologies Ltd. engages in the development of AI and data networks for the financial industry. Its product deploys data science, machine learning and AI technology to evaluate the customers' applications in real time. The company was founded by Gal Krubiner, Sanjiv Das, Yahav Yulzari, and Avital Pardo on March 20, 2016 and is headquartered in New York, NY.

Pagaya Technologies Ltd - Ordinary Shares - Class A

Pagaya Technologies Ltd

Pagaya Technologies is trending as investors react to a positive quarterly earnings report, with community members highlighting strong profitability, institutional confidence, and operational leverage. While some traders express frustration with the stock's volatility and the impact of broader macro headwinds, others remain bullish on the long-term potential for a valuation re-rating.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rockwell Medical (RMTI) Q2 2026 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Rockwell Medical (RMTI) Reports Q2 Loss, Lags Revenue Estimates

Rockwell Medical (RMTI) delivered earnings and revenue surprises of -100.00% and -0.34%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Rockwell Medical Announces Second Quarter 2026 Results

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced financial and operational results for the three and six months ended June...

Village Farms (VFF) Q2 Earnings and Revenues Beat Estimates

Village Farms (VFF) delivered earnings and revenue surprises of +200.00% and +13.99%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Rockwell Medical (RMTI) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Rockwell Medical (RMTI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Curaleaf Holdings, Inc. (CURLF) Q2 Earnings and Revenues Surpass Estimates

Curaleaf Holdings, Inc. (CURLF) delivered earnings and revenue surprises of +125.00% and +2.44%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Rockwell Medical Advances Quality and Regulatory Leadership

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Brian Cox has joined the Company as Vice President, Quality and...

Rockwell Medical Regains Compliance with Nasdaq Listing Requirements

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it has received notice from The Nasdaq Stock Market LLC ("Nasdaq") that...

Rockwell Medical to Release Second Quarter 2026 Results on Thursday, August 13, 2026

Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second...

Kestra Medical Technologies, Ltd. (KMTS) Reports Q4 Loss, Tops Revenue Estimates

Kestra Medical Technologies, Ltd. (KMTS) delivered earnings and revenue surprises of -13.56% and +8.05%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?

• Reported GAAP EPS of -$0.34 up 32.00% YoY
• Reported revenue of $17.78M up 10.63% YoY
• Rockwell Medical reiterates its 2026 annual guidance of $70.0M to $75.0M in net sales, 18% to 22% gross margin, $1.0M to $2.0M in Adjusted EBITDA, and positive operating cash flow.

Rockwell Medical continues to report net losses and flat Adjusted EBITDA performance, while recent structural risks included a mandatory reverse stock split to maintain Nasdaq listing compliance for the company.

Rockwell Medical achieved double-digit revenue growth and expanded gross margins through operational efficiencies, while simultaneously generating positive cash flow and strengthening the company's overall balance sheet and cash position.

Rockwell Medical, Inc. is a biopharmaceutical company, which engages in the development of treatment for anemia, kidney disease, iron deficiency, and hemodialysis. Its products include Triferic, CitraPure, RenalPure and SteriLyte. The company was founded by Robert L. Chioini on October 25, 1996 and is headquartered in Wixom, MI.

Rockwell Medical Inc

Rockwell Medical Announces First Reverse Stock Split In 4 Years – Nasdaq Compliance In Focus As Shares Haven’t Traded Above $1 Since March

Equity

Bullish Sentiment

President Trump has promised to issue a $5,000 "dividend" check to every adult American citizen if the Republican Party wins control of both the House and the Senate in the upcoming midterm elections, though the proposal would require congressional approval and follows his earlier $2,000 tariff-dividend plan, which stalled after the Supreme Court struck down much of his tariff authority. Do you think the $5,000 dividend check actually happens? Vote and explain your reasoning in the comments.

Trump has pledged a $5,000 &quot;dividend&quot; check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Stocktwits

Trump has pledged a $5,000 "dividend" check to every adult American citizen if Republicans win control of both the House and Senate in the midterms. Do you think it actually happens?

Current Price	$8.18
Prev Close	$8.04
Open	$7.87
Dividend Yield	0.00%
50-Day Moving Average	$7.02
Beta	1.18
Avg. Volume	30,331.41
PE Ratio	-5.87

52-Week High	$17.20
52-Week Low	$4.89
Market Capitalization	$32.4M
EPS (Annual)	-$1.52
Price to Book	0.91
Revenue Per Employee	$441,133.76

Feed

News

Sentiment

Earnings

Fundamentals

Info

RMTI Fundamentals